12th Varian Oncology Summit
12th Varian Oncology Summit
12th Varian Oncology Summit
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Adaptive treatment strategies in head &<br />
neck and pelvic regions - The Aarhus<br />
experience with the DART prototype<br />
U. V. Elstrøm, M. Thor, S. Thörnqvist, L. P. Muren,<br />
J. B.B. Petersen and C. Grau<br />
Department of <strong>Oncology</strong> & Department of Medical Physics<br />
Aarhus University Hospital, Aarhus<br />
Denmark<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Berlin, October 2011
Outline<br />
� Dynamic Adaptive Radiotherapy – DART<br />
� Short introduction<br />
� Illustrative case<br />
� Ongoing evaluation<br />
� Head and neck<br />
� Pelvis<br />
� Conclusions<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
2
Background<br />
Adaptation (ART):<br />
� Treatment process in which subsequent delivery can be<br />
modified using a systematic feedback of the geometric and<br />
dosimetric information from previous fractions.<br />
� Based on 3D volumetric information (soft tissue contrast)<br />
� Requires many techniques such as<br />
� image registration (deformable!)<br />
� re-contouring volumes (auto-segmentation!)<br />
� dose reconstruction<br />
� dose accumulation<br />
� treatment evaluation (thresholds!)<br />
� re-optimization (new treatment plan)<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
3
The DART prototype<br />
� Eclipse 10.0 treatment planning (incl. Acuros)<br />
� SmartAdapt 10.0<br />
� CBCT to pCT registration:<br />
• Rigid online match (for plan copy)<br />
• Deformable for dose accumulation<br />
� pCT to CBCT registration:<br />
• Rigid (for structure COM)<br />
• Deformable for structure propagation<br />
� Dose accumulation tool<br />
� Improved CBCT image reconstruction<br />
Manual import of planning and repeat CT’s, treatment plan, CBCT’s with online<br />
registrations and/or raw CBCT projections for improved reconstruction<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
4
Head and neck case<br />
� 70 years old male<br />
� Recurrent lip cancer - T1N2M0<br />
� 6-field IMRT SIB - 66/60/50 Gy in 33 fx.<br />
� Daily CBCT for setup correction; mid-course CT<br />
� All relevant structures in CBCT field-of-view<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
5
Registrations in SmartAdapt<br />
pCT<br />
Daily<br />
CBCT’s<br />
Rigid<br />
pCT vs.<br />
CBCTfx33<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
6
Registrations in SmartAdapt – smooth algorithm<br />
Deform<br />
pCT vs.<br />
CBCTfx33:<br />
Contourpropagation<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
7
Registrations in SmartAdapt<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Rigid (ONLINE) + Deform for dose accumulation<br />
Rigid + Deform for contour propagation<br />
• 4 x 33 registrations !<br />
• Average 8:30 min per fx incl. review & DFC<br />
• Time per fx increases with deformation<br />
(system crash after 2-3 registrations �)<br />
8
Volume statistics in SmartAdapt<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
9
DART prototype – dose accumulation<br />
Dose Record1: Re-calculated<br />
fractional dose on CBCTfx1<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Original treatment plan<br />
Non Adapted plans<br />
=> Re-calculation<br />
Cumulative1: fx1 dose on pCT<br />
10
DART prototype – dose accumulation<br />
Original treatment plan<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
• 3 x 33 plans in Eclipse<br />
• Approx. 1 min per fx<br />
Using Adapted plans the consequences of<br />
various adaptive strategies can be simulated<br />
- difficult in current version due to<br />
system crashes �<br />
Cumulative33: All fx doses on pCT<br />
11
DART prototype – dose accumulation<br />
Daily dose &<br />
accumulated dose<br />
in less than 10 min<br />
per fraction !!!<br />
Similar evaluation using external DIR software:<br />
approx. 45 min per treatment fraction<br />
Elstrøm et al., 2010<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
12
Dose accumulation – what was delivered ?<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
left parotid<br />
right parotid<br />
spinal cord<br />
PVT/<br />
CTV 50<br />
PRV spinal cord<br />
PVT/<br />
CTV 60<br />
PVT/<br />
CTV 66<br />
13
Effect of CBCT image quality ?<br />
� Head and Neck<br />
� (Thorax and pelvis under investigation)<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
14
Improvements in CBCT (diagnostic)<br />
image quality<br />
� Two CBCT image reconstruction methods<br />
� Standard clinical (OBI)<br />
• Uses phantom for beam hardening and scatter correction<br />
� Pre-clinical “Full Fan Experimental” (FFE) using an<br />
adaptive pencil beam based scatter correction algorithm<br />
• Asymmetric scatter kernels to correct for object size, objects<br />
edge effects, detector scatter and anti-scatter grids<br />
• Analytical beam hardening correction based on models of beam<br />
spectrum, filtration in bow tie and object, and detector<br />
response<br />
Details in<br />
Sun and Star-Lack PMB 55 (2010) p6695<br />
Star-Lack et al. Proc SPIE (2009) p7258<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Elstrøm et al., 2011<br />
15
HU-EDR calibration<br />
in CT vs. CBCT<br />
Relative Electron Density Ratio (EDR)<br />
2.0<br />
1.8<br />
1.6<br />
1.4<br />
1.2<br />
1.0<br />
0.8<br />
0.6<br />
0.4<br />
0.2<br />
Catphan<br />
1.0<br />
the treatment planning system<br />
0.9<br />
-150 -100 -50 0 50 100 150 200 250 300<br />
0.0<br />
-1000 -500 0 500 1000 1500 2000<br />
<strong>12th</strong> <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong>Calculated<br />
CT-number (HU)<br />
Relative Electron Density Ratio (EDR)<br />
1.2<br />
1.1<br />
CT Gammex<br />
All these curves goes into<br />
for dose calculation<br />
Calculated CT-number (HU)<br />
Elstrøm et al., submitted 2011<br />
CT PMMA16cm<br />
CT CIRS<br />
HQHOBI PMMA16cm<br />
HQHFFE PMMA16cm<br />
HQHFFE CIRS<br />
HQHOBI CIRS<br />
16
CBCT vs. CT dose calculation<br />
� 8 head and neck cancer patients<br />
� Treated July09 – Nov10 on the same Trilogy unit with IMRT<br />
and daily CBCT (OBI v1.4)<br />
� A high-quality head (100kV/80mA/25ms) CBCT were<br />
performed within hours of the mid-course CT<br />
� CT and CBCT in OBI and FFE reconstruction auto-segmented<br />
from pCT<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Patient Gender Age Site T N<br />
Dose (Gy)<br />
CTV1/CTV2<br />
1 male 70 Recurrent lip cancer T1 N2 66/60<br />
2 female 68 Right parotid T2 N1 66/60<br />
3 male 59 Oropharynx (tonsil) T3 N2b 68/60<br />
4 male 56 Oral cavity (retromolar) T3 N2b 68/60<br />
5 male 45 Unknown primary Tx N2a 66/60<br />
6 female 65 Unknown primary Tx N2b 66/60<br />
7 female 54 Unknown primary Tx N3 68/--<br />
8 male 64 Hypopharynx T3 N2b 68/60<br />
17
Auto-segmented volumes in CBCT vs. CT<br />
Volumes in CBCT were generally 2-5% smaller<br />
than CT volumes, largest for the mandible. The<br />
experimental FFE reconstruction algorithm<br />
reduced the difference slightly.<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
18
Dose calculation in CBCT vs. CT<br />
The average difference between CT-based and CBCT-based<br />
dose calculation were well within 2% for all relevant DVH<br />
parameters in both CTVs and normal tissues<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
19
Auto-segmentation in Pelvis CT’s<br />
� 4 prostate cancer patient with 8-10 repeat CT’s<br />
� Manual segmentation vs. SmartAdapt<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Thörnqvist et al., 2010<br />
20
Auto-segmentation in Pelvis CBCT’s<br />
� 5 prostate cancer patient with 6-8 repeat CBCT’s<br />
� Manual segmentation vs. SmartAdapt<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
Thor et al., 2011<br />
21
Association between quantitative and<br />
qualitative scoring in both studies<br />
� Bladder<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
CT CBCT<br />
22
Dose accumulation<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
23
Conclusions<br />
� DART prototype offers considerable improvements<br />
in the workflow involved in ART<br />
� Tool for developing future adaptive strategies<br />
� First step – what do we deliver today?<br />
� Improvements needed:<br />
� Stability<br />
� Larger FOV in CBCT – stitching of more scans<br />
� Further developed deformable image registration<br />
� Diagnostic image quality in CBCT<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
24
“Future aspect” – Adaptive proton therapy?<br />
� Proton range decisive for dose distribution -> anatomical<br />
changes may cause major change in target and organ<br />
DVH<br />
� Treatment adaptation very important in proton therapy<br />
� Modern hospital based proton facilities:<br />
� Huge investment - calls for high throughput<br />
� Integrated software to handle workflow (re-planning)<br />
efficiently. Like DART…<br />
� <strong>Varian</strong> ProBeam equipped with CBCT for patient setup<br />
approaching diagnostic image quality for direct<br />
calculation of proton range<br />
12 th <strong>Varian</strong> <strong>Oncology</strong> <strong>Summit</strong><br />
25